The Riskalyze Report: Advisors Flee Sovereigns and Utilities

At the request of so many investment advisors, my friends at Riskalyze share the big trends in the assets going into and coming out of advisor portfolios every week. The underlying data is aggregated from hundreds of thousands of client accounts across the $44 billion and counting that advisors manage on the Riskalyze platform*. I hope we can uncover interesting trends for you each week…

Riskalyze

April 27 – May 4th

Winners (advisor flows TO these investments increased substantially):  
  1. Healthcare (IBB, VGHAX, IHE)
  2. Oakmark (OAKLX)
  3. Tesla (TSLA)

Losers (advisor flows FROM these investments increased substantially):

  1. Utilities (XLU)
  2. China (FXI)
  3. International Treasury (IGOV)

Josh here – Elon Musk’s big battery reveal prompted some buying of Tesla common stock by advisors over the last week and some Wall Street firms fell all over themselves reiterating their love affairs buy recs on the name too.

In the sell column, utilities, which have the worst sector chart in the S&P 500 right now – they’re breaking down relative to the broad market and their own uptrend has turned into a topping / consolidation depending on how pessimistic you are on the bond proxy stocks generally.

Advisors are also fleeing the sovereign bond ETFs after a historic (in percentage terms) spike in yields at the long end of the curve captivated the attention of the world. China bulls also took a breather after a steep, sharp correction from overbought conditions in the FXI, which still remains in a longer-term uptrend. There’s a lot of reacting going on in this week’s buys and sells.

A word about Riskalyze:

In my practice, we use Riskalyze software tools to help assess clients’ true risk tolerance and to test portfolio configurations that match up accordingly. It’s changed our practice for the better, as I explain here.

Check it out today!

*(to state the obvious, Riskalyze does not share client sensitive data with me or use animals in testing).

Full Disclosure: Nothing on this site should ever be considered to be advice, research or an invitation to buy or sell any securities, please see my Terms & Conditions page for a full disclaimer.

What's been said:

Discussions found on the web

Read this next.